Eagle Pharmaceuticals Inc (EGRX.OQ)
EGRX.OQ on NASDAQ Stock Exchange Global Market
54.30USD
24 May 2019
54.30USD
24 May 2019
Change (% chg)
$0.76 (+1.42%)
$0.76 (+1.42%)
Prev Close
$53.54
$53.54
Open
$53.84
$53.84
Day's High
$54.60
$54.60
Day's Low
$53.04
$53.04
Volume
37,740
37,740
Avg. Vol
75,913
75,913
52-wk High
$85.66
$85.66
52-wk Low
$36.10
$36.10
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.84 | December | 25 May 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 3 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.40 | 2.40 | 2.40 | 2.40 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 5 | 53.05 | 57.00 | 50.90 | 58.20 |
| Quarter Ending Sep-19 | 5 | 55.75 | 57.75 | 52.50 | 60.80 |
| Year Ending Dec-19 | 5 | 226.19 | 238.00 | 215.80 | 247.58 |
| Year Ending Dec-20 | 5 | 256.94 | 276.01 | 233.50 | 273.73 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 5 | 0.84 | 0.99 | 0.71 | 1.06 |
| Quarter Ending Sep-19 | 5 | 0.88 | 1.08 | 0.71 | 1.05 |
| Year Ending Dec-19 | 5 | 4.03 | 5.00 | 3.38 | 4.14 |
| Year Ending Dec-20 | 5 | 5.08 | 6.62 | 3.10 | 4.65 |
| LT Growth Rate (%) | 1 | 3.20 | 3.20 | 3.20 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-19 | 47.07 | 49.78 | 2.71 | 5.77 |
| Quarter Ending Dec-18 | 54.17 | 56.05 | 1.88 | 3.47 |
| Quarter Ending Sep-18 | 53.43 | 51.34 | 2.10 | 3.92 |
| Quarter Ending Jun-18 | 51.23 | 59.30 | 8.07 | 15.74 |
| Quarter Ending Mar-18 | 48.88 | 46.63 | 2.25 | 4.60 |
| Earnings (per share) | ||||
| Quarter Ending Mar-19 | 0.73 | 1.01 | 0.28 | 38.36 |
| Quarter Ending Dec-18 | 1.18 | 1.20 | 0.02 | 1.48 |
| Quarter Ending Sep-18 | 0.98 | 1.18 | 0.20 | 20.41 |
| Quarter Ending Jun-18 | 0.80 | 0.95 | 0.15 | 18.45 |
| Quarter Ending Mar-18 | 0.69 | 0.53 | 0.16 | 22.63 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 53.05 | 53.05 | 52.80 | 55.16 | 58.20 |
| Quarter Ending Sep-19 | 55.75 | 55.75 | 54.70 | 55.66 | 60.80 |
| Year Ending Dec-19 | 226.19 | 226.19 | 218.04 | 222.96 | 247.58 |
| Year Ending Dec-20 | 256.94 | 256.94 | 246.88 | 243.50 | 273.73 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 0.84 | 0.84 | 0.95 | 1.09 | 1.06 |
| Quarter Ending Sep-19 | 0.88 | 0.88 | 0.98 | 1.08 | 1.05 |
| Year Ending Dec-19 | 4.03 | 4.03 | 4.02 | 4.43 | 4.14 |
| Year Ending Dec-20 | 5.08 | 5.08 | 4.76 | 4.84 | 4.65 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-19 | 0 | 0 | 2 | 1 |
| Quarter Ending Sep-19 | 0 | 0 | 2 | 1 |
| Year Ending Dec-19 | 0 | 0 | 4 | 0 |
| Year Ending Dec-20 | 0 | 0 | 3 | 1 |
| Earnings | ||||
| Quarter Ending Jun-19 | 0 | 0 | 0 | 3 |
| Quarter Ending Sep-19 | 0 | 0 | 0 | 3 |
| Year Ending Dec-19 | 0 | 0 | 3 | 1 |
| Year Ending Dec-20 | 0 | 0 | 3 | 1 |
Earnings vs. 
Estimates